With the Redecan Acquisition, HEXO is Two Years Away from a Reckoning Scott Willis·May 31, 2021Marijuana Analysis·11 Comments·
Is Verano the New Must Own Cannabis Stock ·February 18, 2021Is Verano a solid addition to any Cannabis Portfolio? We've gone digging to find out....Marijuana Analysis·12 Comments·
Aphria Offers Big Upside if the Tilray Deal Closes ·February 10, 2021Aphria offers 90% upside, but this return won't come for free...Marijuana Analysis·9 Comments·
Locked & Lit: The Grizzle Cannabis Portfolio Scott Willis·January 19, 2021See how Grizzle invests in the emerging cannabis industry. Our proprietary portfolio revealed....Marijuana Analysis·9 Comments·
Why Curaleaf Chairman Boris Jordan is Building Value Not Cashing Out Scott Willis·December 16, 2020An interview filled with insights from the chairman of the largest cannabis company in North America...Marijuana Analysis·9 Comments·
The U.S. Election Cannabis Playbook Part 2 Scott Willis·October 30, 2020A step by step guide to buying cannabis stocks under any election scenario. Individual portfolios for every election...Marijuana Analysis·10 Comments·
The U.S. Election Cannabis Playbook Part 1 Scott Willis·October 27, 2020Breaking down the future of cannabis legalization depending on how Americans vote in the 2020 elections....Marijuana Analysis·15 Comments·
Aphria 1Q 2021 Earnings – Prices in Freefall Scott Willis·October 20, 2020Aphria is putting up the best results in Canada but when compared against US peers, investors need to...Marijuana Analysis·7 Comments·
Does Pure Sunfarms Make Village Farms a Buy? Scott Willis·September 10, 2020Now that Village Farms is the low cost greenhouse leader, is now the time to go all-in?...Marijuana Analysis·9 Comments·
